What happened Shire Pharmaceuticals?

Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019. Shire was a global biotechnology company focused on serving people with rare diseases and other highly specialized conditions….Shire (pharmaceutical company)

Type	Subsidiary
Founded	1986
Defunct	2019
Fate	Acquired by Takeda
Headquarters	Massachusetts, United States

Who owns Shire Pharmaceuticals?

Takeda Pharmaceutical Company
Shire/Parent organizations

Was Shire bought by Takeda?

Only eight months after the acceptance of its offer, Japanese pharma company Takeda completed its acquisition of international biotech Shire in January 2019.

Where is Takeda US headquarters?

Deerfield, Illinois, United States
Takeda Pharmaceuticals U.S.A., Inc./Headquarters locations

How much did Takeda buy Shire for?

Overall, Takeda made five public bids for Shire. Under the final bid, Shire agreed to be acquired for about $62.2 billion (U.S.), or $66.22 per share, made up of $30.33 per share in cash and 0.839 shares of Takeda stock. It also included Shire’s debt, bringing the acquisition closer to $80 billion.

Does Takeda own millennium?

Millennium: The Takeda Oncology Company combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan’s largest pharmaceutical company. In May, 2008, Millennium was acquired by Takeda Pharmaceutical Company Limited.

Why is Takeda leaving Deerfield?

Takeda announced last fall that it would close its U.S. headquarters in Deerfield and move the work to Boston following its acquisition of Irish drugmaker Shire. Takeda told Deerfield employees on Tuesday that all of them would leave the complex by Dec. 31.

Does Takeda make Adderall?

Takeda Canada Inc. is now the market authorization holder for ADDERALL XR®. Click here to view the Product Monograph.

What is Takeda known for?

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.

Which pharma company was sold in friendly takeover to Japanese company?

TOKYO (Reuters) – Takeda Pharmaceutical Co Ltd 4502. T said on Thursday it has agreed to buy U.S. biotechnology company Millennium Pharmaceuticals Inc MLNM. O for $8.8 billion to bolster its cancer drug business, in the biggest overseas acquisition by a Japanese drugmaker.

Where are the headquarters of the company Shire?

In addition, Shire owns manufacturing sites in Lexington, Massachusetts, and Social Circle, Georgia. Shire’s headquarters in Lexington, Massachusetts, will be integrated with Takeda’s new U.S. headquarters, which is being relocated from Deerfield, Illinois, to the Boston area.

How to get in touch with Shire Pharmaceuticals?

Shire Pharmaceuticals Portugal Lda. Taipei 110, Taiwan. Büyükdere Cad. Bahar Sok. No:13 Kat:24 We welcome your interest in partnerships at Shire. Our contact form provides our current key areas of strategic fit. The site uses cookies to provide you with a more responsive and personalized service.

What was the value of the acquisition of Shire?

Shire changed the name of ViroPharma to Shire Viropharma Inc. upon acquisition and on their final day of trading the company was valued at $3.3 billion. At $4.2 billion, ViroPharma set a new company record.

When did NPS Pharmaceuticals get acquired by Shire?

In 2014 Shire acquired two rare disease drug companies: Fibrotech with its antifibrotic compounds for $75 million, and Lumena, a company researching rare gastro-intestinal and hepatic compounds, for $260 million. In 2015, NPS Pharmaceuticals was acquired for $5.2 billion, bringing along its rare disease drugs Gattex and Natpara.